MD-reviewed ·  Healthcare editorial
MedAI Verdict
AI medical scribes

Reference AS-221  ·  AI Medical Scribe

Iris Medical

by Iris Medical  ·  founded 2023

Specialty workflow-focused ambient scribe.

Visit Iris MedicalRead our methodology

At a glance

Pricing
Subscription.
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
2023

Independent score  ·  By our public rubric

13/100Tracked
How it’s computed →
  • Regulatory & Compliance
    0/25

    No FDA clearance listed

  • Clinical Integration
    0/38.2

    No EHR integrations listed

  • Evidence Strength
    4.9/10

    2 peer-reviewed papers

  • Vendor & Market
    6/18

    market_relevance=40 (seed or unfunded)

  • Sentiment & Transparency
    2.5/14

    1 pricing tier(s) but no $ amounts (contact-sales pattern)

▸ Show all 11 dimensions

Regulatory & Compliance

  • FDA clearance0/12

    No FDA clearance listed

  • HIPAA / SOC2 / BAA0/13

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/21

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/12

    None of the top-3 EHRs covered

  • Bidirectional write-back0/5

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers5/7

    2 peer-reviewed papers

  • RCT / meta-analysis / systematic review0/3

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal3/12

    market_relevance=40 (seed or unfunded)

  • Years in market3/6

    Founded 2023 (3 years)

Sentiment & Transparency

  • Clinician sentiment (Reddit)0/9

    No clinician sentiment data available

  • Pricing transparency3/5

    1 pricing tier(s) but no $ amounts (contact-sales pattern)

Last computed May 26, 2026 · Rubric v1.0.0

Bottom line

Specialty workflow-focused ambient scribe.

Free tier available.

Editorial review pending

We do not yet have enough independent sources for Iris Medical to publish a full editorial review. A complete review requires peer-reviewed coverage, clinician sentiment from public forums, or hands-on testing notes from our editorial team.

The vendor overview below reflects what we have verified from the vendor and from our category-level reporting. When additional sources surface, the review is regenerated automatically and dated. If you have direct hands-on experience and want to share it on the record, write to editorial@medaiverdict.com.

Overview

Emerging scribe with specialty-workflow templates.

Pricing

What it costs

Free tier only; no paid plans publicly disclosed.

TierMonthlyAnnualNotes
Plan——Subscription.

Source: vendor pricing page. Verified July 2, 2026.

Vendor stability

Who builds it

Iris Medical (Iris Medical) was founded in 2023, putting it 3 years into market.

Peer-reviewed coverage

What the literature says

2 peer-reviewed studies indexed on PubMed evaluate Iris Medical in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.

Diode Laser Transscleral Cyclophotocoagulation With a Novel Low-Cost Torchlight Method of Trans-Corneal Transillumination in Refractory Pediatric Glaucoma.
Choudhary S, Snehi S, Singh A, et al.· J Glaucoma· 2024
Trans-corneal transillumination (TI) aided transscleral cyclophotocoagulation (TSCPC) for intraocular pressure control of refractory pediatric glaucoma was found to be effective at 1 year. To study 1-year outcomes of diode laser TSCPC with trans-corneal TI using a novel low-cost torchlight method in refractory pediatric glaucoma. This prospective interventional study included children with refractory glaucoma who underwent TSCPC with the Oculight laser system (IRIS Medical Instruments) with trans-corneal TI (TSCPC-TI) using a novel low-cost torchlight method. Children completing a minimum 1-y…
The lowering of the intraocular pressure and the retinal venous pressure by cyclophotocoagulation.
Kremmer S, Youssef L, Manoiu R, et al.· BMC Ophthalmol· 2026
To measure whether cyclophotocoagulation (CPC) can reduce not only intraocular pressure (IOP) but also retinal venous pressure (RVP) in glaucoma patients. This retrospective study included 36 eyes of 23 patients with primary open angle glaucoma in whom RVP was measured before and after CPC. In 13 patients both eyes were included in the study and in 10 patients only one eye. Instruments: Applanation tonometry. Measurement of RVP: Slow inflation of a pad lateral to the cornea under observation of the retinal veins (IOPstim, IMEDOS Health GmbH, Jena, Germany). When a venous pulse appears, measur…

See all on PubMed

In the same category

Other ai medical scribes

See the full ai medical scribes ranking